368 related articles for article (PubMed ID: 24723052)
1. Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.
Costa VV; Fagundes CT; Valadão DF; Ávila TV; Cisalpino D; Rocha RF; Ribeiro LS; Ascenção FR; Kangussu LM; Celso MQ; Astigarraga RG; Gouveia FL; Silva TA; Bonaventura D; Sampaio Dde A; Leite AC; Teixeira MM; Souza DG
Med Microbiol Immunol; 2014 Aug; 203(4):231-50. PubMed ID: 24723052
[TBL] [Abstract][Full Text] [Related]
2. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
[TBL] [Abstract][Full Text] [Related]
3. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.
Fagundes CT; Costa VV; Cisalpino D; Amaral FA; Souza PR; Souza RS; Ryffel B; Vieira LQ; Silva TA; Atrasheuskaya A; Ignatyev G; Sousa LP; Souza DG; Teixeira MM
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1449. PubMed ID: 22206036
[TBL] [Abstract][Full Text] [Related]
5. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease.
Zellweger RM; Prestwood TR; Shresta S
Cell Host Microbe; 2010 Feb; 7(2):128-39. PubMed ID: 20153282
[TBL] [Abstract][Full Text] [Related]
6. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
7. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.
Pan P; Zhang Q; Liu W; Wang W; Lao Z; Zhang W; Shen M; Wan P; Xiao F; Liu F; Zhang W; Tan Q; Liu X; Wu K; Liu Y; Li G; Wu J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413130
[TBL] [Abstract][Full Text] [Related]
8. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
9. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
10. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
[TBL] [Abstract][Full Text] [Related]
11. Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans.
Zompi S; Montoya M; Pohl MO; Balmaseda A; Harris E
PLoS Negl Trop Dis; 2012; 6(3):e1568. PubMed ID: 22448292
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
13. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.
Tuiskunen A; Wahlström M; Bergström J; Buchy P; Leparc-Goffart I; Lundkvist A
Virol J; 2011 Aug; 8():398. PubMed ID: 21835036
[TBL] [Abstract][Full Text] [Related]
15. The Role of Heterotypic DENV-specific CD8
Talarico LB; Batalle JP; Byrne AB; Brahamian JM; Ferretti A; García AG; Mauri A; Simonetto C; Hijano DR; Lawrence A; Acosta PL; Caballero MT; Paredes Rojas Y; Ibañez LI; Melendi GA; Rey FA; Damonte EB; Harris E; Polack FP
EBioMedicine; 2017 Jun; 20():202-216. PubMed ID: 28483582
[TBL] [Abstract][Full Text] [Related]
16. Immune response to dengue virus and prospects for a vaccine.
Murphy BR; Whitehead SS
Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187
[TBL] [Abstract][Full Text] [Related]
17. Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar.
Ngwe Tun MM; Thant KZ; Inoue S; Kurosawa Y; Lwin YY; Lin S; Aye KT; Thet Khin P; Myint T; Htwe K; Mapua CA; Natividad FF; Hirayama K; Morita K
J Med Virol; 2013 Jul; 85(7):1258-66. PubMed ID: 23595687
[TBL] [Abstract][Full Text] [Related]
18. Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity.
Sun P; García J; Comach G; Vahey MT; Wang Z; Forshey BM; Morrison AC; Sierra G; Bazan I; Rocha C; Vilcarromero S; Blair PJ; Scott TW; Camacho DE; Ockenhouse CF; Halsey ES; Kochel TJ
PLoS Negl Trop Dis; 2013; 7(7):e2298. PubMed ID: 23875036
[TBL] [Abstract][Full Text] [Related]
19. A lethal model of disseminated dengue virus type 1 infection in AG129 mice.
Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N
J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904
[TBL] [Abstract][Full Text] [Related]
20. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
